Anest. intenziv. Med. 2013;24(2):102-106

A brief review of obstetrics analgesia practised in the United KingdomPostgraduate education

Matloch Zdeněk1,2,*, Matlochová Sylvie1
1 South Devon Healthcare NHS Trust, Torbay District General Hospital, Devon, United Kingdom
2 Klinika anesteziologie a resuscitace, Kardiocentrum, Institut klinické a experimentální medicíny, Praha

There are several techniques of labour analgesia. Non-regional techniques have predominantly supportive role and inhalation of Entonox is preferred over systemic opioid administration. Inhalation of Entonox is very popular in the United Kingdom. It provides reasonable analgesia and is suitable mainly in hospitals where other analgesic options are limited. The Entonox is being self-administered by the parturients which also provides a certain degree of satisfaction. The gold standard among regional techniques is epidural analgesia, offering the best analgesia. Several recently conducted randomised controlled trials confirm that epidural analgesia is not associated with an increased incidence of LSCS (Low Segment Caesarean Section) or backache after childbirth. However, several studies have demonstrated a modest prolongation of the second stage of labour and an increase in the operative vaginal delivery rate. Remifentanil PCA is a relatively new method of labour analgesia and is mainly indicated for mothers in whom epidural analgesia is contraindicated or difficult/impossible to establish.

Keywords: labour analgesia; Entonox; Remifentanil; epidural analgesia

Published: April 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matloch Z, Matlochová S. A brief review of obstetrics analgesia practised in the United Kingdom. Anest. intenziv. Med. 2013;24(2):102-106.
Download citation

References

  1. www.frca.co.uk
  2. Guidelines South Devon Healthcare NHS Trust
  3. Peck, T. E., Hill, S. A., Williams, M. Pharmacology for Anaes-thesia and Intensive Care. Third Edition, Cambridge Press, 2008, p. 121. Go to original source...
  4. Al-Shaikh, B., Stacey, S. Essentials of Anaesthetic Equipment. Churchill Livingstone Elsevier, 2007, p. 10-11.
  5. Glass, P. S. A., Hardman, D., Kamayama, Y. et al. Preliminary pharmakokinetics and pharmacodynamics of an ultra-shortacting opioid: Remifentanil. Anaesthesia Analgesia, 1993, 77, s. 1031-1040. Go to original source... Go to PubMed...
  6. Amin, H. M., Soopchak, A. M., Esposito, R. N., Graham, C. L., Batenhurst, R. L., Camporesi, E. M. Naloxone reversal of depressed ventilatory response to hypoxia during continuous infusion of Remifentanil. Anaesthesiology, 1993, 79, p. 1203.
  7. Kan, R. E., Hughes, S. C., Rosen, M. A. et al. Intravenous Remifentanil: Placental transfer, maternal and neonatal effects. Anaesthesiology, 1998, 88, p. 1467-1479. Go to original source... Go to PubMed...
  8. Thurlow, J. A., Waterhouse, P. Patient controlled analgesia in labour using Remifentanil in two parturients with platelet abnormalities. British Journal of Anaesthesiology, 2000, 84, p. 411-413. Go to original source... Go to PubMed...
  9. Jones, R., Pegrum, A., Stacey, R. G. W. Patient controlled analgesia using Remifentanil in the parturient with thrombocytopaenia. Anaesthesia, 1999, 54, p. 459-465. Go to original source... Go to PubMed...
  10. Olufalabi, A. J., Booth, J. V., Wakeling, H. G. et al. A preliminary investigation of Remifentanil as a labour analgesic. Anaesthesia Analgesia, 2000, 92, p. 606-608. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.